Regenxbio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Regenxbio using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-06 | $-1.17 | $-1.12 | -4.46 % |
Q2 | 2024-08-01 | $-1.05 | $-1.29 | 18.6 % |
Q1 | 2024-05-08 | $-1.38 | $-1.26 | -9.52 % |
Q4 | 2024-02-27 | $-1.43 | $-1.27 | -12.6 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-06 | $24.20M | $23.59M | 2.57 % |
Q2 | 2024-08-01 | $22.30M | $22.97M | -2.94 % |
Q1 | 2024-05-08 | $15.62M | $23.52M | -33.6 % |
Q4 | 2024-02-27 | $22.21M | $34.00M | -34.7 % |
Regenxbio (RGNX) is scheduled to report earnings on February 25, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $-1.17, which missed the estimate of $-1.12.
The Actual Revenue was $24.2M, which beat the estimate of $23.6M.
Browse earnings estimates, EPS, and revenue on all stocks.